| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Asymchem Laboratories (Tianjin) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.55 |
| 52 Week High | CN¥14.10 |
| 52 Week Low | CN¥5.55 |
| Beta | 0.10 |
| 11 Month Change | -12.60% |
| 3 Month Change | -20.71% |
| 1 Year Change | -45.05% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -76.09% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7K90 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -3.5% | -5.0% | 0.4% |
| 1Y | -45.0% | -17.0% | 3.9% |
Return vs Industry: 7K90 underperformed the German Pharmaceuticals industry which returned -14.6% over the past year.
Return vs Market: 7K90 underperformed the German Market which returned 4.2% over the past year.
Price Volatility
| 7K90 volatility | |
|---|---|
| 7K90 Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.5% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: 7K90's share price has been volatile over the past 3 months.
Volatility Over Time: 7K90's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 9,788 | Hao Hong | www.asymchem.com.cn |
Asymchem Laboratories (Tianjin) Co., Ltd. engages in the provision of contract development and manufacturing services focuses on innovation and commercial application of global pharmaceutical technology in Mainland China and internationally. The company offers research and development, and production services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services.
Asymchem Laboratories (Tianjin) Co., Ltd. Fundamentals Summary
| 7K90 fundamental statistics | |
|---|---|
| Market cap | €3.04b |
| Earnings (TTM) | €246.73m |
| Revenue (TTM) | €896.25m |
12.6x
P/E Ratio3.5x
P/S RatioIs 7K90 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7K90 income statement (TTM) | |
|---|---|
| Revenue | CN¥6.98b |
| Cost of Revenue | CN¥3.46b |
| Gross Profit | CN¥3.51b |
| Other Expenses | CN¥1.59b |
| Earnings | CN¥1.92b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.46 |
| Gross Margin | 50.36% |
| Net Profit Margin | 27.53% |
| Debt/Equity Ratio | 0.07% |
How did 7K90 perform over the long term?
See historical performance and comparison